Trulieve Cannabis CORP

Trulieve Cannabis Corp. announced the elimination of its Chief Accounting Officer position and the termination of Brett Walsh, appointing CFO Jan Reese as principal accounting officer.

Trulieve Cannabis Corp. announced the immediate departure of President Jason Pernell, effective June 11, 2026.

Trulieve Cannabis Corp. reports strong shareholder approval for director elections and auditor ratification at its recent annual meeting.

Trulieve Cannabis Corp. has authorized a share repurchase program allowing for the buyback of up to $50 million in subordinate voting shares over a 12-month period.

Trulieve Cannabis Corp. has deconsolidated its mixed-use cannabis business, Harvest Enterprises, LLC, to prepare for a potential New York Stock Exchange listing.

Trulieve Cannabis Corp. announced first quarter 2026 results, reporting $287 million in revenue, a 59% gross margin, and $2 million in net income, alongside $100 million in Adjusted EBITDA.

Trulieve Cannabis Corp. reports a decrease in revenue for Q1 2026 compared to Q1 2025, primarily due to retail price compression, while Adjusted EBITDA shows a slight decline.

Trulieve Cannabis Corp. reported a significantly reduced net loss and increased cash reserves in its third quarter, driven by expense control and adult-use sales, despite facing a substantial IRS tax dispute.

Trulieve Cannabis Corp. reported improved gross profit and Adjusted EBITDA for Q2 2025, but saw its net loss increase significantly due to escalating uncertain tax liabilities.

Trulieve Cannabis Corp. announces its financial results for the first quarter of 2025, showing a slight increase in revenue and improved gross profit margin.

Trulieve Cannabis Corp. saw a revenue increase and a significant jump in gross profit in the third quarter of 2024, despite a net loss, as the company continues to navigate the evolving cannabis market.

Trulieve Cannabis Corp. saw a 7.7% increase in revenue in the second quarter of 2024 compared to the same period last year, alongside improved gross profit margins.

Trulieve Cannabis Corp. reports a slight revenue dip but improved net loss and increased Adjusted EBITDA for 2025, while actively managing debt and anticipating federal cannabis reclassification.

Trulieve Cannabis Corp. reports a 5.1% increase in revenue for 2024, driven by retail and wholesale growth, alongside improved gross profit margins.

Trulieve Cannabis Corp. released its 2023 annual report, outlining financial results, strategic initiatives, and risk factors in the competitive cannabis market.

Trulieve Cannabis Corp. Chairman and CEO Kim Rivers has sold a portion of her holdings as part of a pre-arranged trading plan.

Trulieve Cannabis Corp. CEO Kim Rivers has sold a significant number of subordinate voting shares as part of a pre-arranged trading plan.

Trulieve Cannabis Corp. CEO Kim Rivers reported significant changes in her beneficial ownership, including a conversion of multiple voting shares and new equity grants.

Trulieve Cannabis Corp. President Jason Pernell received grants of 58,594 restricted stock units and 41,668 stock options.

Trulieve Cannabis Corp.'s Chief Corporate Affairs & Strategy, Christine Ann Hersey, received grants of restricted stock units and stock options.

Trulieve Cannabis Corp.'s Chief Production Officer, Kyle Landrum, received grants of restricted stock units and stock options, aligning executive incentives with long-term company performance.

Trulieve Cannabis Corp. has announced a special meeting of shareholders to vote on a plan of arrangement to relocate its corporate domicile from British Columbia to Delaware.

Trulieve Cannabis Corp. files an amendment to its definitive proxy statement to correct the record date for the 2025 annual general and special meeting of shareholders.

Trulieve Cannabis Corp. has filed definitive additional materials with the SEC related to its proxy statement.

Trulieve Cannabis Corp. announces its annual general and special meeting of shareholders to be held virtually on June 12, 2025, including proposals for director elections, executive compensation, and an amendment to the 2021 Omnibus Incentive Plan.

Trulieve Cannabis Corp. has filed definitive additional materials with the SEC related to its proxy statement.

Trulieve Cannabis Corp. is holding its annual general and special meeting virtually on June 12, 2024, to vote on key proposals including director elections, executive compensation, and an incentive plan amendment.

AdvisorShares Trust has reported beneficial ownership of 10,641,152 subordinate voting shares, representing 6.26% of the class, in Trulieve Cannabis Corp. as of June 30, 2026.

Marex Securities Products Inc. and Marex Group plc have reported a passive beneficial ownership of 5.8% in Trulieve Cannabis Corp.'s Subordinate Voting Shares.